News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Seely Lynn
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/19/2022 |
4
| Seely Lynn (President and CEO) has filed a Form 4 on Lyell Immunopharma, Inc.|
Txns:
| Granted 7,500,000 options to buy
@ $3.28, valued at
$24.6M
|
|
| 06/30/2022 |
4
| Seely Lynn (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 2,600 shares
@ $0
Granted 5,300 options to buy
@ $50.64, valued at
$268.4k
|
|
| 06/10/2022 |
4
| Seely Lynn (Director) has filed a Form 4 on Lyell Immunopharma, Inc.|
Txns:
| Granted 65,000 options to buy
@ $5.31, valued at
$345.2k
|
|
| 06/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/04/2021 |
4
| Seely Lynn (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 2,250 shares
@ $0
Granted 4,500 options to buy
@ $87.13, valued at
$392.1k
|
|
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2020 |
4
| Seely Lynn (Principal Executive Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 197,659 shares
@ $0
Granted 302,693 options to buy
@ $8.08, valued at
$2.4M
|
|
| 06/20/2019 |
4
| Seely Lynn (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 4,875 options to buy
@ $96.77, valued at
$471.8k
Granted 1,312 restricted stock units
@ $0 |
|
| 04/09/2019 |
4
| Seely Lynn (Principal Executive Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 330,660 options to buy
@ $24.44, valued at
$8.1M
|
|
| 06/25/2018 |
4
| Seely Lynn (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 7,500 options to buy
@ $69.79, valued at
$523.4k
|
|
| 04/18/2018 |
4
| Seely Lynn (Principal Executive Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 248,450 options to buy
@ $21.87, valued at
$5.4M
|
|
| 06/23/2017 |
4
| Seely Lynn (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 10,909 options to buy
@ $46.02, valued at
$502k
|
|
| 06/02/2017 |
4
| Seely Lynn (Principal Executive Officer) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 564,111 shares
@ $0 |
|
| 05/17/2017 |
4
| Seely Lynn (Principal Executive Officer) has filed a Form 4 on Myovant Sciences Ltd. |
| 10/26/2016 |
3
| Seely Lynn (Principal Executive Officer) has filed a Form 3 on Myovant Sciences Ltd. |
| 06/27/2016 |
4
| Seely Lynn (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 10,909 options to buy
@ $19.53, valued at
$213.1k
|
|
| 04/15/2016 |
4
| Seely Lynn (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 21,818 options to buy
@ $19.08, valued at
$416.3k
|
|
| 04/15/2016 |
3
| Seely Lynn (Director) has filed a Form 3 on Blueprint Medicines Corp |
| 02/18/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/11/2015 |
4
| Seely Lynn (Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Granted 5,500 shares
@ $0 |
|
| 12/22/2014 |
4
| Seely Lynn (Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Exercised 20,686 options to buy
@ $10.585, valued at
$219k
Exercised 10,654 options to buy
@ $9.385, valued at
$100k
|
|
| 10/23/2014 |
4
| Seely Lynn (Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Sold 5,000 shares
@ $99.0283, valued at
$495.1k
Exercised 5,000 options to buy
@ $10.585, valued at
$52.9k
|
|
| 10/17/2014 |
4
| Seely Lynn (Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Sold 3,000 shares
@ $87.61, valued at
$262.8k
Sold 12,300 shares
@ $88.94, valued at
$1.1M
Sold 8,946 shares
@ $89.82, valued at
$803.5k
Sold 100 shares
@ $90.41, valued at
$9k
Sold 5,000 shares
@ $93.97, valued at
$469.9k
Exercised 5,000 options to buy
@ $10.585, valued at
$52.9k
Exercised 4,346 options to buy
@ $9.385, valued at
$40.8k
Exercised 15,000 options to buy
@ $6.735, valued at
$101k
Exercised 5,000 options to buy
@ $10.585, valued at
$52.9k
|
|
| 09/18/2014 |
4
| Seely Lynn (Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Sold 13,300 shares
@ $96.85, valued at
$1.3M
Sold 13,300 shares
@ $97.66, valued at
$1.3M
Sold 3,400 shares
@ $98.16, valued at
$333.7k
Sold 17,800 shares
@ $99.55, valued at
$1.8M
Sold 7,200 shares
@ $100.44, valued at
$723.2k
Exercised 10,000 options to buy
@ $10.585, valued at
$105.9k
Exercised 5,000 options to buy
@ $9.385, valued at
$46.9k
Exercised 15,000 options
@ $6.735, valued at
$101k
Exercised 25,000 options
@ $10.585, valued at
$264.6k
|
|
| 09/11/2014 |
4
| Seely Lynn (Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Sold 14,813 shares
@ $94.44, valued at
$1.4M
Sold 5,187 shares
@ $95.06, valued at
$493.1k
Exercised 20,000 options to buy
@ $10.585, valued at
$211.7k
|
|
| 08/28/2014 |
4
| Seely Lynn (Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Sold 5,700 shares
@ $88.953, valued at
$507k
Sold 11,700 shares
@ $89.43, valued at
$1M
Sold 2,600 shares
@ $90.42, valued at
$235.1k
Exercised 5,700 options to buy
@ $10.585, valued at
$60.3k
Exercised 14,300 options to buy
@ $10.585, valued at
$151.4k
|
|
| 08/14/2014 |
4
| Seely Lynn (Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Sold 11,000 shares
@ $83.12, valued at
$914.3k
Sold 5,700 shares
@ $84.01, valued at
$478.9k
Sold 3,300 shares
@ $84.63, valued at
$279.3k
Exercised 12,500 options to buy
@ $9.385, valued at
$117.3k
Exercised 7,500 options to buy
@ $6.735, valued at
$50.5k
|
|
| 08/12/2014 |
4
| Seely Lynn (Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Sold 4,300 shares
@ $80.77, valued at
$347.3k
Sold 2,900 shares
@ $81.6, valued at
$236.6k
Sold 2,500 shares
@ $82.4, valued at
$206k
Sold 3,300 shares
@ $83.9, valued at
$276.9k
Sold 12,500 shares
@ $84.01, valued at
$1.1M
Exercised 13,000 options to buy
@ $9.385, valued at
$122k
Exercised 12,500 options to buy
@ $9.385, valued at
$117.3k
|
|
| 07/23/2014 |
4
| Seely Lynn (Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Sold 7,500 shares
@ $73.9613, valued at
$554.7k
Exercised 7,500 options to buy
@ $6.735, valued at
$50.5k
|
|
| 07/07/2014 |
4
| Seely Lynn (Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Sold 12,000 shares
@ $79.0162, valued at
$948.2k
Exercised 12,000 options to buy
@ $9.385, valued at
$112.6k
|
|
| 06/19/2014 |
4
| Seely Lynn (Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Sold 6,500 shares
@ $74.42, valued at
$483.7k
Sold 1,000 shares
@ $75.03, valued at
$75k
Sold 5,500 shares
@ $74.82, valued at
$411.5k
Sold 2,000 shares
@ $75.51, valued at
$151k
Exercised 7,500 options to buy
@ $6.735, valued at
$50.5k
Exercised 7,500 options to buy
@ $6.735, valued at
$50.5k
|
|
| 02/20/2014 |
4
| Seely Lynn (Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Granted 39,000 options to buy
@ $83.55, valued at
$3.3M
|
|
| 02/06/2014 |
4
| Seely Lynn (Chief Medical Officer) has filed a Form 4 on MEDIVATION, INC.|
Txns:
| Granted 7,000 shares
@ $0 |
|
|
|
|